Sickle Cell Anemia (HbSS)

2

Review clinical trials related to Sickle Cell Anemia (HbSS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease

The goal of this interventional study is to learn about the impact of an intervention for health care providers that teaches individuation and perspective-taking (IPT) skills to enhance patient-centered communication in pediatric sickle cell disease (SCD). The main question it aims to answer is: Does an intervention that teaches individuation and perspective-taking (IPT) skills to pediatric sickle cell disease (SCD) health care providers (HCPs) enhance patient-centered communication? Researchers will compare the IPT intervention to a control group who will receive education about SCD pain management to see if the IPT intervention improves patient-centered communication. Participants will complete baseline surveys and then be randomly assigned into the intervention or control group. After completing their assigned session (IPT training or education), they will be asked to complete the same surveys as completed at baseline.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Connecticut Children's Medical CenterUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Licensed health care provider (HCP) who provides care to youth with SCD [+1]

HCP who does not provide care to youth with SCD [+3]

Status: Recruiting

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

The main reason for this research study is to learn more about hydroxyurea and the treatment of sickle cell anemia (SCA). Hydroxyurea is a medication that has been studied for many years and has been shown to provide benefits for people with SCA. In this research study, the investigators hope to learn more about how to improve the dosing and monitoring of hydroxyurea and learn more about the long-term effects of hydroxyurea over time. Hydroxyurea is usually dosed based only on your weight. Our study will use a new way to select a starting dose that is based on how each patient absorbs hydroxyurea.

Participants needed: 50
Trial details
Phase: Phase 4Age: 6+Biological sex: AllType: InterventionalSponsor: Children's Hospital Medical Center, CincinnatiUpdated: Sep 16, 2025Locations: 1
Eligibility criteria

Diagnosis of sickle cell anemia (HbSS) or sickle-β0-thalassemia (HbSβ0) [+2]

Current treatment with regularly scheduled blood transfusions [+1]